Stockscreener 앱 받기
4.19
4.49%
0.18
전일 마감가:
$4.01
열려 있는:
$4.13
하루 거래량:
1.45M
Relative Volume:
1.97
시가총액:
$271.82M
수익:
$207.32M
순이익/손실:
$-61.04M
주가수익비율:
-4.3751
EPS:
-0.9577
순현금흐름:
$-25.97M
1주 성능:
+7.16%
1개월 성능:
+52.36%
6개월 성능:
+68.27%
1년 성능:
-23.26%
1일 변동 폭
$4.05
$4.375
1주일 범위
$3.755
$4.469
52주 변동 폭
$1.17
$7.78
트리스 메디컬 컨셉트 Stock (TMCI) Company Profile
명칭
Treace Medical Concepts Inc
전화
(904) 373-5940
주소
100 PALMETTO PARK PLACE, PONTE VEDRA
Compare TMCI vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TMCI
Treace Medical Concepts Inc
|
4.19 | 271.82M | 207.32M | -61.04M | -25.97M | -0.9577 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
트리스 메디컬 컨셉트 Stock (TMCI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-07 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-11-07 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2025-02-04 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2024-12-31 | 개시 | Lake Street | Buy |
| 2024-12-17 | 재개 | JP Morgan | Neutral |
| 2024-05-16 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-05-08 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-05-08 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-05-08 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-05-08 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-05-08 | 다운그레이드 | Truist | Buy → Hold |
| 2023-09-29 | 개시 | UBS | Buy |
| 2023-05-01 | 개시 | Truist | Buy |
| 2023-04-11 | 개시 | Stephens | Equal-Weight |
| 2022-05-12 | 개시 | BTIG Research | Buy |
| 2022-01-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-18 | 개시 | JP Morgan | Overweight |
| 2021-05-18 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-05-18 | 개시 | SVB Leerink | Outperform |
| 2021-05-18 | 개시 | Stifel | Buy |
모두보기
트리스 메디컬 컨셉트 주식(TMCI)의 최신 뉴스
Treace Medical Concepts (TMCI) Q2 2024 earnings summary - Quartr
Treace Medical Concepts (TMCI) Proxy filing Summary - Quartr
Treace Medical Concepts (TMCI) Sidoti Small-Cap Virtual Investor Conference Summary - Quartr
Treace treats its first patient with HyperPlate XM foot implant - Stock Titan
Treace Medical Concepts Inc - TradingKey
Treace Medical Concepts Inc (TMCI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Treace Medical Concepts Inc (TMCI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Treace Medical Concepts Inc (TMCI) Institutional Confidence - TradingKey
Treace Medical Concepts Inc (TMCI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Treace Medical Concepts Inc (TMCI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Treace Medical Concepts Inc (TMCI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Treace Medical Concepts Inc (TMCI) Valuation: PE, PB & Fair Value Analysis - TradingKey
Treace Medical Concepts Inc (TMCI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Treace Medical Concepts Balances Growth With Earnings Strain - TipRanks
Treace Medical Concepts CEO John T. Treace buys $99,195 in stock - Investing.com UK
Treace Medical Concepts CEO John T. Treace buys $99,195 in stock By Investing.com - Investing.com South Africa
Treace Medical (TMCI) CEO boosts direct stake with June share buys - Stock Titan
Treace Medical Concepts CEO John T. Treace buys $210,967 in stock By Investing.com - Investing.com Australia
Treace Medical Concepts CEO John T. Treace buys $210,967 in stock - Investing.com
Treace Medical (NASDAQ: TMCI) CEO adds 52,317 shares in open-market purchases - Stock Titan
Treace to Present at the Sidoti Small Cap Conference - The Manila Times
Treace to showcase bunion surgery tech at Sidoti Small Cap Conference - Stock Titan
TMCI Q1 2026 Earnings: Narrowed Loss Beats Expectations Amidst Operational FocusEarnings Call Transcript - newsline.com
Treace Medical CEO John Treace buys $177,915 in company stock By Investing.com - Investing.com Nigeria
Treace Medical CEO John Treace buys $177,915 in company stock - Investing.com
Treace Medical (TMCI) CEO buys 50,000 shares in open-market trade - Stock Titan
Treace Medical (NASDAQ:TMCI) CEO John Treace acquires $340,588 in shares - Investing.com Australia
Treace Medical Concepts Insider Bought Shares Worth $340,589, According to a Recent SEC Filing - marketscreener.com
Treace Medical Concepts (TMCI) CEO buys 115,520 shares of stock - Stock Titan
William Blair Investment Management LLC Sells 2,488,883 Shares of Treace Medical Concepts, Inc. $TMCI - MarketBeat
Treace Medical Concepts (TMCI) Declines 2.11% as Stock Nears Key Support at $2.64Covered Call ETF - The Legal Advocate
Treace Medical Concepts, Inc. 8-K SEC Filing Details and Company Information (May 19, 2026) - Minichart
Treace Medical Shareholders Back Directors, Pay and Auditor - TipRanks
Treace Medical Concepts shareholders elect directors and approve key proposals - Investing.com Australia
Treace Medical Concepts shareholders elect directors and approve key proposals By Investing.com - Investing.com South Africa
Treace Medical (TMCI) shareholders elect directors and ratify auditor at 2026 meeting - Stock Titan
TMCI SEC FilingsTreace Medical Concepts, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Director at Treace Medical (TMCI) receives 30,000 restricted stock units - Stock Titan
Treace Medical (NASDAQ: TMCI) director gets 30,000 RSUs, holds 75,243 - Stock Titan
Armistice Capital (TMCI) discloses 6.36M shares, 9.85% stake - Stock Titan
Treace Medical Concepts Q1 earnings call highlights - MSN
Treace Medical Concepts Insider Bought Shares Worth $375,505, According to a Recent SEC Filing - Moomoo
Treace Medical Concepts CEO John Treace buys $375,505 in shares By Investing.com - Investing.com Australia
Treace Medical Concepts CEO John Treace buys $375,505 in shares - Investing.com
TMCI (TMCI) CEO John Treace purchases over 150,000 company shares in open market - Stock Titan
Bank of America (TMCI) reports 3.53M shares, 5.5% ownership - Stock Titan
트리스 메디컬 컨셉트 (TMCI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.93%
자본화:
|
볼륨(24시간):